• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    1/3/24 12:58:41 PM ET
    $ABVC
    $AEVA
    $ARWR
    $ATXG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $ABVC alert in real time by email

    Shares of SoFi Technologies, Inc. (NASDAQ:SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.

    Keefe, Bruyette & Woods analyst Michael Perito downgraded SoFi from a Market Perform rating to an Underperform rating and lowered the price target from $7.50 to $6.50, citing recent outperformance and a change in the analyst's model.

    SoFi Technologies shares dipped 12.8% to $8.41 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • NexImmune, Inc. (NASDAQ:NEXI) shares rose 150.8% to $6.14 after gaining over 6% on Tuesday.
    • Trinity Place Holdings Inc. (NYSE:TPHS) rose gained 62.6% to $0.1857. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024.
    • Sigma Additive Solutions, Inc.(NASDAQ:SASI) gained 60.3% to $4.65. Sigma Additive Solutions, announced in an 8-K Filing, the approval of the issuance of the shares of common stock in exchange for all the capital stock of NextTrip Holdings.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) jumped 58.3% to $1.90. ABVC BioPharma and its subsidiary received $460 million from AiBtl BioPharma as the first milestone payment of global licensing fees.
    • Sidus Space, Inc. (NASDAQ:SIDU) rose 48.4% to $10.35. Sidus Space secured NOAA approval to provide imaging services to government and commercial customers.
    • Brera Holdings PLC (NASDAQ:BREA) shares gained 32.8% to $0.97.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares gained 31.2% to $5.01. Roth MKM raised price target on the stock to $40.
    • Elicio Therapeutics, Inc. (NASDAQ:ELTX) gained 29% to $7.65.
    • TDCX Inc. (NYSE:TDCX) gained 28% to $6.18 after it disclosed receiving a preliminary non-binding acquisition offer.
    • Ucommune International Ltd (NASDAQ:UK) shares gained 27% to $5.14 after gaining 9% on Tuesday.
    • OneMedNet Corporation (NASDAQ:ONMD) jumped 24% to $0.93. The company said OneMedNet iRWD(TM) is now available on AWS Data Exchange.
    • Hongli Group Inc. (NASDAQ:HLP) rose 23.6% to $2.68.
    • Aeva Technologies, Inc. (NYSE:AEVA) gained 19.3% to $0.8715. Aeva said that one of the top global automotive OEMs has selected Aeva as its Tier 1 LiDAR supplier for its series production vehicle program.
    • Dyne Therapeutics, Inc. (NASDAQ:DYN) shares jumped 16.2% to $15.17. Dyne Therapeutics released initial clinical data from its ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1) and its DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.
    • Voyager Therapeutics, Inc. (NASDAQ:VYGR) rose 16.1% to $10.45.
    • Carbon Revolution Public Limited Company (NASDAQ:CREV) rose 15.8% to $27.01.
    • Gaotu Techedu Inc. (NYSE:GOTU) rose 15.1% to $3.7601.
    • Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) gained 7% to $33.17. Arrowhead Pharmaceuticals reported pricing of offering of 15.79 million shares at $28.50 per share.
    • Anavex Life Sciences Corp. (NASDAQ:AVXL) gained 6.5% to $6.44. HC Wainwright & Co. analyst Raghuram Selvaraju maintained Anavex Life Sciences with a Buy and lowered the price target from $54 to $40.

    Losers

    • E-Home Household Service Holdings Limited (NASDAQ:EJH) fell 60.2% to $1.52.
    • RiskOn International, Inc. (NASDAQ:ROI) shares fell 37.1% to $0.2886. RiskOn International, in partnership with Meetkai, announced the launch of "askROI.com."
    • Infobird Co., Ltd (NASDAQ:IFBD) tumbled 35% to $0.8922.
    • Pinstripes Holdings Inc. (NYSE:PNST) shares fell 29.1% to $9.44 after surging 22% on Tuesday. Pinstripes and Banyan Acquisition Corporation announced they have closed their previously announced business combination, which was approved by Banyan’s stockholders at a meeting on Dec. 27, 2023.
    • Esperion Therapeutics, Inc. (NASDAQ:ESPR) dipped 25.5% to $2.1750 after the company announced a $125 million amendment to the collaboration with Japanese pharma company Daiichi Sankyo Co., Ltd.
    • Nemaura Medical Inc. (NASDAQ:NMRD) fell 25.5% to $0.1403.
    • Peraso Inc. (NASDAQ:PRSO) fell 22.4% to $7.33.
    • Taoping Inc. (NASDAQ:TAOP) fell 21.1% to $1.4830.
    • Kelso Technologies Inc. (NASDAQ:KIQ) fell 20.8% to $0.1814.
    • The OLB Group, Inc. (NASDAQ:OLB) declined 20.7% to $0.8001.
    • Signing Day Sports, Inc. (NYSE:SGN) fell 20.7% to $0.8345 after declining around 7% on Tuesday.
    • Hallmark Financial Services, Inc. (NASDAQ:HALL) declined 20.6% to $0.9913.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) fell 18.5% to $2.55. TC BioPharm announced additional cost reduction steps to improve financial standing and streamline efficiencies.
    • Tenax Therapeutics, Inc. (NASDAQ:TENX) dipped 16.5% to $17.35.
    • Jin Medical International Ltd. (NASDAQ:ZJYL) fell 15.3% to $216.00.
    • Porch Group, Inc. (NASDAQ:PRCH) fell 13.1% to $2.6405.
    • Yoshiharu Global Co. (NASDAQ:YOSH) shares fell 11.4% to $6.01 after gaining 25% on Tuesday.
    • SunPower Corporation (NASDAQ:SPWR) dipped 11.3% to $4.3250.
    • Sunrun Inc. (NASDAQ:RUN) fell 11.1% to $17.30.
    • Addentax Group Corp. (NASDAQ:ATXG) shares fell 10.8% to $1.3199.
    • Inspire Medical Systems, Inc. (NYSE:INSP) fell 10% to $169.13.
    • Livent Corporation (NASDAQ:LTHM) fell 9.8% to $16.26.
    • Polished.com Inc. (NYSE:POL) fell 9.6% to $8.30 after jumping 52% on Tuesday.
    • Zoomcar Holdings, Inc. (NASDAQ:ZCAR) shares fell 9% to $2.72 after dipping around 19% on Tuesday.
    • Xerox Holdings Corporation (NYSE:XRX) fell 8.8% to $16.44.
    • Kohl's Corporation (NYSE:KSS) dipped 8.4% to $25.67.
    • UniFirst Corporation (NYSE:UNF) fell 8.4% to $165.16 following first-quarter results.
    • Opendoor Technologies Inc. (NASDAQ:OPEN) fell 7.9% to $3.9409. JMP Securities analyst Nicholas Jones maintained Opendoor Technologies with an Outperform and raised the price target from $3.5 to $5.

     

    Now Read This: Ethereum Falls Below $2,300; Bonk Becomes Top Loser

    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $AEVA
    $ARWR
    $ATXG

    CompanyDatePrice TargetRatingAnalyst
    Arrowhead Pharmaceuticals Inc.
    $ARWR
    4/21/2026$100.00Equal-Weight → Overweight
    Morgan Stanley
    SoFi Technologies Inc.
    $SOFI
    4/15/2026Hold
    Argus
    Elicio Therapeutics Inc.
    $ELTX
    4/15/2026$20.00Buy
    Ladenburg Thalmann
    SoFi Technologies Inc.
    $SOFI
    3/19/2026$19.00Equal Weight
    Wells Fargo
    Tenax Therapeutics Inc.
    $TENX
    3/17/2026$35.00Overweight
    Cantor Fitzgerald
    Kohl's Corporation
    $KSS
    3/11/2026$23.00 → $17.00Market Perform
    Telsey Advisory Group
    Elicio Therapeutics Inc.
    $ELTX
    3/10/2026$17.00Buy
    Rodman & Renshaw
    Unifirst Corporation
    $UNF
    3/6/2026$250.00Underweight → Equal Weight
    Barclays
    More analyst ratings

    $ABVC
    $AEVA
    $ARWR
    $ATXG
    SEC Filings

    View All

    SEC Form 144 filed by Dyne Therapeutics Inc.

    144 - Dyne Therapeutics, Inc. (0001818794) (Subject)

    4/23/26 4:46:15 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Dyne Therapeutics Inc.

    144 - Dyne Therapeutics, Inc. (0001818794) (Subject)

    4/23/26 4:45:31 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Dyne Therapeutics Inc.

    144 - Dyne Therapeutics, Inc. (0001818794) (Subject)

    4/23/26 4:45:18 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $AEVA
    $ARWR
    $ATXG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, CHAIRMAN AND FOUNDER Ehrlichman Matt sold $983,952 worth of shares (121,242 units at $8.12), decreasing direct ownership by 0.71% to 16,928,071 units (SEC Form 4) to satisfy withholding tax

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/23/26 6:08:21 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    Chief Operating Officer Neagle Matthew sold $509,668 worth of shares (62,801 units at $8.12), decreasing direct ownership by 2% to 2,485,878 units (SEC Form 4) (tax liability)

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/23/26 6:07:32 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    CHIEF FINANCIAL OFFICER Tabak Shawn sold $62,734 worth of shares (7,730 units at $8.12), decreasing direct ownership by 2% to 382,559 units (SEC Form 4) (withholding obligation)

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/23/26 6:06:09 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $AEVA
    $ARWR
    $ATXG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $AEVA
    $ARWR
    $ATXG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe

    – If confirmed by the European Commission, REDEMPLO would be the first and only siRNA medicine authorized in the EU for both genetically confirmed and clinically diagnosed adult patients with FCS – People living with FCS have extremely high triglyceride levels and a substantially higher risk of acute pancreatitis and related long-term complications, often resulting in a reduced quality of life – The CHMP opinion is based on positive results from the Phase 3 PALISADE study where REDEMPLO reduced triglycerides by a median of 80% from baseline and significantly fewer cases of acute pancreatitis were seen in patients using REDEMPLO compared with those using placebo Arrowhead Pharmaceutica

    4/24/26 6:39:00 AM ET
    $ARWR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    WALTHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 18 new employees. The awards were made as an inducement material to the new employees' acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement equity awards consisted of non-statutory stock options to purchase up to an aggregate of 320,900 shares of Dyne's common stock at a per share exercise price equal to the closing price of Dyne's common stock on The Nasdaq

    4/23/26 4:05:00 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sidus Space Advances its Fortis Next-Generation Command and Data Handling (C&DH) System

    Microchip collaboration enables accelerated, modular, and mission‑scalable OpenVPX architectures for space and defense applications CAPE CANAVERAL, Fla., April 23, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced continued advancements to its Fortis Command and Data Handling (C&DH) platform, a modular 3U OpenVPX system designed to support rapid development, configuration flexibility, and long-term scalability across next-generation space and defense missions. Supported by a strate

    4/23/26 8:31:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $ABVC
    $AEVA
    $ARWR
    $ATXG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Noto Anthony bought $500,516 worth of shares (28,900 units at $17.32), increasing direct ownership by 0.25% to 11,704,352 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/17/26 4:05:47 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Director Posner Brian S bought $38,700 worth of shares (2,000 units at $19.35), increasing direct ownership by 17% to 13,500 units (SEC Form 4)

    4 - Dyne Therapeutics, Inc. (0001818794) (Issuer)

    3/13/26 4:46:19 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Posner Brian S bought $45,180 worth of shares (3,000 units at $15.06), increasing direct ownership by 35% to 11,500 units (SEC Form 4)

    4 - Dyne Therapeutics, Inc. (0001818794) (Issuer)

    3/10/26 5:33:53 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $AEVA
    $ARWR
    $ATXG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Arrowhead upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Arrowhead from Equal-Weight to Overweight and set a new price target of $100.00

    4/21/26 7:27:56 AM ET
    $ARWR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Argus initiated coverage on SoFi Technologies

    Argus initiated coverage of SoFi Technologies with a rating of Hold

    4/15/26 8:10:03 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Ladenburg Thalmann initiated coverage on Elicio Therapeutics with a new price target

    Ladenburg Thalmann initiated coverage of Elicio Therapeutics with a rating of Buy and set a new price target of $20.00

    4/15/26 8:08:24 AM ET
    $ELTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $AEVA
    $ARWR
    $ATXG
    Leadership Updates

    Live Leadership Updates

    View All

    Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

    Mr. Staab has over 25 years of financial and executive experience across the healthcare industry CHAPEL HILL, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (NASDAQ:TENX) ("Tenax" or "Tenax Therapeutics" or the "Company"), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, announced today the appointment of Thomas R. Staab, II as Chief Financial Officer (CFO), effective May 11, 2026. Mr. Staab brings over 25 years of leadership experience across management and corporate finance roles in the healthcare industry. He will replace Thomas McGauley, who has served as interim CFO since December 2024. "Tom br

    4/22/26 7:00:00 AM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SoFi, Kelsea Ballerini, and CMA Launch Amplify Your Ambitions Contest to Empower America's Next Generation of Emerging Artists

    Emerging artists can win up to $200,000 and take the stage at an exclusive CMA Fest concert, as SoFi helps turn ambitions into financial realities SoFi, the one-stop shop for digital financial services, is launching the "Amplify Your Ambitions" Contest, a nationwide search to discover emerging artists as they pursue their ambitions and advance their careers, in partnership with the Country Music Association (CMA) and multi-platinum songwriter, producer, and author Kelsea Ballerini, a five-time GRAMMY® Award nominee and multiple ACM and CMA Award winner. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414427860/en/SoFi Amplif

    4/15/26 9:00:00 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Xerox Board of Directors Appoints Louie Pastor as Chief Executive Officer

    Company reaffirms 2026 financial guidance Xerox Holdings Corporation (NASDAQ:XRX) today announced that Steve Bandrowczak will step down as Chief Executive Officer, and the Board of Directors has appointed Louie Pastor as Chief Executive Officer, effective immediately. "On behalf of the Board and the entire Xerox team, I want to thank Steve for his leadership during a pivotal period for the company, including the successful acquisitions and integrations of Lexmark and ITsavvy," said Scott Letier, Chairman of the Xerox Board of Directors. "Louie brings a strong combination of operational discipline, strategic insight, and deep familiarity with Xerox. Throughout his time with the company,

    3/30/26 8:30:00 AM ET
    $XRX
    Computer peripheral equipment
    Technology

    $ABVC
    $AEVA
    $ARWR
    $ATXG
    Financials

    Live finance-specific insights

    View All

    Esperion to Report First Quarter 2026 Financial Results on May 7

    ANN ARBOR, Mich., April 23, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced it will report first quarter 2026 financial results before the market opens on Thursday, May 7, 2026. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. A live audio webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days. About Esperion Therapeutics Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical c

    4/23/26 8:00:00 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results

    Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it will host a webcast and conference call on May 7, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 second quarter ended March 31, 2026. Webcast and Conference Call Details Investors may access a live audio webcast on the Events and Presentations page under the Investors section of the Arrowhead website. A replay of the webcast will be available approximately two hours after the conclusion of the call. For analysts that wish to participate in the conference call, please register at https://register-conf.media-server.com/register/BI94a3f6754bd3471e8e895704fb645ee5. Once registered, you will r

    4/20/26 4:01:00 PM ET
    $ARWR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Opendoor 1Q26 Financial Open House on May 7th, 2026

    SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- Today, Opendoor Technologies Inc. ("Opendoor") (NASDAQ:OPEN) announced that it will report first quarter 2026 financial results for the period ended March 31, 2026 following the close of the market on Thursday, May 7, 2026. Modernizing Investor AccessOn May 7, 2026, management will host our Financial Open House video livestream at 2:00 p.m. PT (5:00 p.m. ET) to discuss the company's business and financial results. We believe in building in the open. The Financial Open House replaces the traditional earnings conference call with a video event, including a live segment for shareholder Q&A. Shareholder Q&AWe invite shareholders to participa

    4/16/26 9:00:00 AM ET
    $OPEN
    Real Estate
    Finance

    $ABVC
    $AEVA
    $ARWR
    $ATXG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Hongli Group Inc.

    SC 13G - Hongli Group Inc. (0001855557) (Subject)

    12/12/24 6:49:27 PM ET
    $HLP
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Hongli Group Inc.

    SC 13G - Hongli Group Inc. (0001855557) (Subject)

    12/12/24 6:47:57 PM ET
    $HLP
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Hongli Group Inc.

    SC 13G - Hongli Group Inc. (0001855557) (Subject)

    12/12/24 6:45:55 PM ET
    $HLP
    Industrial Machinery/Components
    Industrials